Monte Rosa’s platform is centered around protein surfaces. By encoding geometric and physiochemical properties on a discrete set of canonical, and non canonical, surface patches of proteins, the company rationally designs molecular glues for a wide range of therapeutic targets.
Founders
Chief Executive Officer
Markus Warmuth